Intraoperative anaphylaxis to neuromuscular blocking agents: The incidence over 9 years at two tertiary hospitals in South Korea

European Journal of Anaesthesiology

Volumn 33, Issue 5, 2016, Pages 368-378

  Cho, Youn J ^a   Ju, Jae W ^a   Sim, Hyunyee ^b   Lee, Jong Hwan ^b   Hong, Deok M ^a   Kim, Tae K ^a   Min, Jeong Jin ^b   Song, Woo Jung ^c   Kang, Hye Ryun ^c   Cho, Sang Heon ^c   Jeon, Yunseok ^a  

^a Seoul National University Hospital   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM BESILATE; CISATRACURIUM; ROCURONIUM; SUXAMETHONIUM; VECURONIUM; ANDROSTANE DERIVATIVE; NEUROMUSCULAR BLOCKING AGENT;

ADOLESCENT; ADULT; AGED; ANAPHYLAXIS; CONFERENCE PAPER; DISEASE SEVERITY; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; INCIDENCE; INTRAOPERATIVE ANAPHYLAXIS; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PEROPERATIVE COMPLICATION; RETROSPECTIVE STUDY; SKIN TEST; SOUTH KOREA; TERTIARY CARE CENTER; ADVERSE EFFECTS; CHEMICALLY INDUCED; CLINICAL TRIAL; ELECTRONIC HEALTH RECORD; MIDDLE AGED; MULTICENTER STUDY; NEUROMUSCULAR BLOCKING; PEROPERATIVE CARE; RISK FACTOR; TIME FACTOR;

ADOLESCENT; ADULT; AGED; ANAPHYLAXIS; ANDROSTANOLS; ELECTRONIC HEALTH RECORDS; FEMALE; HUMANS; INCIDENCE; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS; SKIN TESTS; TERTIARY CARE CENTERS; TIME FACTORS; VECURONIUM BROMIDE;

EID: 84963830909     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0000000000000373     Document Type: Conference Paper

References (35)

1. Johansson SG, Bieber T, Dahl R, et al. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004; 113: 832-836
2. Harper NJ, Dixon T, Dugue P, et al. Suspected anaphylactic reactions associated with anaesthesia. Anaesthesia 2009; 64: 199-211
3. Gibbs NM, Sadleir PH, Clarke RC, Platt PR. Survival from perioperative anaphylaxis in Western Australia 2000-2009. Br J Anaesth 2013; 111: 589-593
4. Mertes PM, Malinovsky JM, Jouffroy L, et al. Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice. J Investig Allergol Clin Immunol 2011; 21: 442-453
5. Laxenaire MC. Epidemiology of anesthetic anaphylactoid reactions. Fourth multicenter survey (July 1994-December 1996). Ann Fr Anesth Reanim 1999; 18: 796-809
6. Mertes PM, Laxenaire MC. Allergic reactions occurring during anaesthesia. Eur J Anaesthesiol 2002; 19: 240-262
7. Harboe T, Guttormsen AB, Irgens A, et al. Anaphylaxis during anesthesia in Norway: a 6-year single-center follow-up study. Anesthesiology 2005; 102: 897-903
8. Mertes PM, Alla F, Trechot P, et al., Groupe d'Etudes des Reactions Anaphylactoides Peranesthesiques. Anaphylaxis during anesthesia in France: an 8-year national survey. J Allergy Clin Immunol 2011; 128: 366-373
9. Sadleir PH, Clarke RC, Bunning DL, Platt PR. Anaphylaxis to neuromuscular blocking drugs: incidence and cross-reactivity in Western Australia from 2002 to 2011. Br J Anaesth 2013; 110: 981-987
10. Guttormsen AB. Allergic reactions during anaesthesia -increased attention to the problem in Denmark and Norway. Acta Anaesthesiol Scand 2001; 45: 1189-1190
11. Heier T, Guttormsen AB. Anaphylactic reactions during induction of anaesthesia using rocuronium for muscle relaxation: a report including 3 cases. Acta Anaesthesiol Scand 2000; 44: 775-781
12. Baillard C, Korinek AM, Galanton V, et al. Anaphylaxis to rocuronium. Br J Anaesth 2002; 88: 600-602
13. Mertes PM, Laxenaire MC, Alla F, Groupe d'Etudes des Reactions Anaphylactoides Peranesthesiques. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology 2003; 99: 536-545
14. Rose M, Fisher M. Rocuronium: high risk for anaphylaxis? Br J Anaesth 2001; 86: 678-682
15. Bhananker SM, O'Donnell JT, Salemi JR, Bishop MJ. The risk of anaphylactic reactions to rocuronium in the United States is comparable to that of vecuronium: an analysis of food and drug administration reporting of adverse events. Anesth Analg 2005; 101: 819-822
16. Kroigaard M, Garvey LH, Gillberg L, et al. Scandinavian Clinical Practice Guidelines on the diagnosis, management and follow-up of anaphylaxis during anaesthesia. Acta Anaesthesiol Scand 2007; 51: 655-670
17. Sampson HA, Munoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report -Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006; 117: 391-397
18. Simons FE, Ardusso LR, Bilo MB, et al. World Allergy Organization anaphylaxis guidelines: summary. J Allergy Clin Immunol 2011; 127: 587-593
19. Brockow K, Romano A, Blanca M, et al. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 2002; 57: 45-51
20. SFAR Working Group. Clinical Practice Guidelines. Reducing the risk of anaphylaxis during anaesthesia. Abbreviated text. Ann Fr Anesth Reanim 2002; 21 (Suppl 1): 7s-23s
21. Mertes PM, Laxenaire MC, Gerap. Anaphylactic and anaphylactoid reactions occurring during anaesthesia in France. Seventh epidemiologic survey (January 2001-December 2002). Ann Fr Anesth Reanim 2004; 23: 1133-1143
22. Mertes PM, Laxenaire MC, Lienhart A, et al. Reducing the risk of anaphylaxis during anaesthesia: guidelines for clinical practice. J Investig Allergol Clin Immunol 2005; 15: 91-101
23. MertesPM,Moneret-Vautrin DA,Leynadier F, LaxenaireMC.Skin reactions to intradermal neuromuscular blocking agent injections: a randomized multicenter trial in healthy volunteers. Anesthesiology 2007; 107: 245-252
24. Brockow K, Garvey LH, Aberer W, et al. Skin test concentrations for systemically administered drugs -an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy 2013; 68: 702-712
25. Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1977; 1: 466-469
26. Laake JH, Rottingen JA. Rocuronium and anaphylaxis -a statistical challenge. Acta Anaesthesiol Scand 2001; 45: 1196-1203
27. Aziz MF, Healy D, Kheterpal S, et al. Routine clinical practice effectiveness of the Glidescope in difficult airway management: an analysis of 2,004 Glidescope intubations, complications, and failures from two institutions. Anesthesiology 2011; 114: 34-41
28. Wappler F. Anesthesia for patients with a history of malignant hyperthermia. Curr Opin Anaesthesiol 2010; 23: 417-422
29. Johansson SG, Florvaag E, Oman H, et al. National pholcodine consumption and prevalence of IgE-sensitization: a multicentre study. Allergy 2010; 65: 498-502
30. Katelaris CH, Kurosawa M, Moon HB, et al. Pholcodine consumption and immunoglobulin E-sensitization in atopics from Australia, Korea, and Japan. Asia Pac Allergy 2014; 4: 86-90
31. Yang MS, Lee SH, Kim TW, et al. Epidemiologic and clinical features of anaphylaxis in Korea. Ann Allergy Asthma Immunol 2008; 100: 31-36
32. Ewan PW, Dugue P, Mirakian R, et al. BSACI guidelines for the investigation of suspected anaphylaxis during general anaesthesia. Clin Exp Allergy 2010; 40: 15-31
33. Song WJ, Chang YS. Recent applications of basophil activation tests in the diagnosis of drug hypersensitivity. Asia Pac Allergy 2013; 3: 266-280
34. Reddy JI, Cooke PJ, van Schalkwyk JM, et al. Anaphylaxis is more common with rocuronium and succinylcholine than with atracurium. Anesthesiology 2015; 122: 39-45
35. Brusch AM, Clarke RC, Platt PR, Phillips EJ. Exploring the link between pholcodine exposure and neuromuscular blocking agent anaphylaxis. Br J Clin Pharmacol 2014; 78: 14-23